Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 31

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05078047Phase 3Active Not Recruiting
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
Basal Cell CarcinomaCervical CancerColorectal Carcinoma With Microsatellite Instability+12 more
PrincipalinvestigatorStart date: 2022-03-08

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Cancer of the Uterine CervixEndometrial CarcinomaCancer of Head and Neck+4 more
Similarity Score13%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCancer of the Uterine CervixCancer of Head and Neck
Similarity Score6%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

MelanomaCancer of the Uterine Cervix
Similarity Score4%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Cancer of Head and NeckCarcinoma, Merkel Cell
Similarity Score4%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Cancer of the Uterine CervixEndometrial Carcinoma
Similarity Score4%

Francesco Perrone, M.D., Ph.D.

National Cancer Institute, Naples

Related
13 trials

Shared therapeutic areas:

Cancer of the Uterine CervixEndometrial Carcinoma
Similarity Score4%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Esophageal Squamous Cell CarcinomaCarcinoma, Hepatocellular
Similarity Score4%

Jason Wu

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Related
31 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCancer of the Uterine Cervix
Similarity Score4%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score2%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05078047Phase 3PrincipalInvestigator

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Basal Cell CarcinomaCervical CancerColorectal Carcinoma With Microsatellite Instability+12 more
Active Not Recruiting

All 1 trials loaded